Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease in serum testosterone concentration during treatment with tetracycline.

M O Pulkkinen, J Mäenpää

    Acta Endocrinologica
    |June 1, 1983
    PubMed
    Summary

    Tetracycline treatment significantly lowers serum testosterone concentrations. Sex hormone binding globulin (SHBG) levels and the free testosterone index remained unaffected during the study. This suggests a direct impact of tetracycline on testosterone levels.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2024
    Same author

    NSGO-OV-UMB1/ENGOT-OV30: A phase II study of durvalumab in combination with the anti-CD73 monoclonal antibody Oleclumab in patients with relapsed ovarian cancer.

    Gynecologic oncology·2024
    Same author

    Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2023
    Same author

    INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.

    British journal of cancer·2023
    Same author

    Expression Analysis of Platinum Sensitive and Resistant Epithelial Ovarian Cancer Patient Samples Reveals New Candidates for Targeted Therapies.

    Translational oncology·2018
    Same author

    Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease.

    Annals of oncology : official journal of the European Society for Medical Oncology·2016

    Area of Science:

    • Endocrinology
    • Pharmacology
    • Reproductive Health

    Background:

    • Testosterone is a crucial hormone for male reproductive health and overall well-being.
    • Sex hormone binding globulin (SHBG) influences the bioavailability of testosterone.
    • Antibiotics, including tetracycline, can have various systemic effects, but their impact on hormonal balance is not fully understood.

    Purpose of the Study:

    • To investigate the effect of tetracycline treatment on serum testosterone concentrations.
    • To assess changes in sex hormone binding globulin (SHBG) capacity during tetracycline therapy.
    • To evaluate the impact on the free testosterone index.

    Main Methods:

    • Serum samples were collected from participants before, during, and after a course of tetracycline treatment.
    • Concentrations of total testosterone were measured.
    • Binding capacity of sex hormone binding globulin (SHBG) was determined.

    Main Results:

    • Serum testosterone concentrations were significantly lower during tetracycline treatment compared to control periods (17 +/- 0.9 vs 21 +/- 0.8 nmol/l, P < 0.01).
    • No significant differences were observed in SHBG levels between treatment and control days.
    • The 'free testosterone index' mirrored the changes observed in total testosterone, indicating a consistent effect.

    Conclusions:

    • Tetracycline treatment leads to a significant reduction in serum testosterone levels.
    • SHBG levels and the calculated free testosterone index are not affected by tetracycline.
    • These findings suggest a potential endocrine-disrupting effect of tetracycline on testosterone production or metabolism.

    Related Experiment Videos